OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects
Gabriele Bianco, Matteo Boattini, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 41, Iss. 1, pp. 63-70
Closed Access | Times Cited: 40
Gabriele Bianco, Matteo Boattini, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 41, Iss. 1, pp. 63-70
Closed Access | Times Cited: 40
Showing 26-50 of 40 citing articles:
Evolution of ceftazidime–avibactam resistance driven by mutations in double-copy bla KPC-2 to bla KPC-189 during treatment of ST11 carbapenem-resistant Klebsiella pneumoniae
Xiaofan Zhang, Yinrong Xie, Ying Zhang, et al.
mSystems (2024)
Open Access | Times Cited: 3
Xiaofan Zhang, Yinrong Xie, Ying Zhang, et al.
mSystems (2024)
Open Access | Times Cited: 3
Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol
Gabriele Bianco, Matteo Boattini, Monica Cricca, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14132-14153
Open Access | Times Cited: 3
Gabriele Bianco, Matteo Boattini, Monica Cricca, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14132-14153
Open Access | Times Cited: 3
Complete Genome Sequence of a Klebsiella pneumoniae Strain Carrying Novel Variant blaKPC-203, Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023
Stefano Amadesi, Gabriele Bianco, Benedetta Secci, et al.
Pathogens (2024) Vol. 13, Iss. 6, pp. 507-507
Open Access | Times Cited: 2
Stefano Amadesi, Gabriele Bianco, Benedetta Secci, et al.
Pathogens (2024) Vol. 13, Iss. 6, pp. 507-507
Open Access | Times Cited: 2
In vivo development of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae infections: a case series
Matteo Boattini, Gabriele Bianco, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2024)
Open Access | Times Cited: 2
Matteo Boattini, Gabriele Bianco, Sara Comini, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2024)
Open Access | Times Cited: 2
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study
Laura Campogiani, Pietro Vitale, A Lodi, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 820-820
Open Access | Times Cited: 6
Laura Campogiani, Pietro Vitale, A Lodi, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 820-820
Open Access | Times Cited: 6
Activity of cefiderocol and synergy of novel β-lactam-β-lactamase inhibitor-based combinations against metallo-β-lactamase-producing gram-negative bacilli: insights from a two-year study (2019–2020)
Matteo Boattini, Sara Comini, Gabriele Bianco, et al.
Journal of Chemotherapy (2022) Vol. 35, Iss. 3, pp. 198-204
Closed Access | Times Cited: 9
Matteo Boattini, Sara Comini, Gabriele Bianco, et al.
Journal of Chemotherapy (2022) Vol. 35, Iss. 3, pp. 198-204
Closed Access | Times Cited: 9
Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms
Gabriele Bianco, Paolo Gaibani, Sara Comini, et al.
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1681-1681
Open Access | Times Cited: 9
Gabriele Bianco, Paolo Gaibani, Sara Comini, et al.
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1681-1681
Open Access | Times Cited: 9
The Effectiveness of Imipenem–Relebactam against Ceftazidime-Avibactam Resistant Variants of the KPC-2 β-Lactamase
Krisztina M. Papp‐Wallace, Melissa D. Barnes, Magdalena A. Taracila, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 892-892
Open Access | Times Cited: 4
Krisztina M. Papp‐Wallace, Melissa D. Barnes, Magdalena A. Taracila, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 892-892
Open Access | Times Cited: 4
In vitro activity of cefiderocol against comparators (ceftazidime-avibactam, ceftazidime-avibactam/ aztreonam combination, and colistin) against clinical isolates of meropenem-resistant Klebsiella pneumoniae from India
Kalyani Borde, M. Abdul Kareem, Ratna Mani Sharma, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 4
Kalyani Borde, M. Abdul Kareem, Ratna Mani Sharma, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 4
β-Lactam antibiotics
Jed F. Fisher, Yuanyuan Qian, Shahriar Mobashery
Elsevier eBooks (2023), pp. 67-113
Closed Access | Times Cited: 3
Jed F. Fisher, Yuanyuan Qian, Shahriar Mobashery
Elsevier eBooks (2023), pp. 67-113
Closed Access | Times Cited: 3
Rapid ResaCeftazidime-Avibactam Enterobacterales NP Test: Rapid Detection of Ceftazidime-Avibactam Susceptibility in Enterobacterales
Luozhu Feng, Yining Zhao, Zhuocheng Yao, et al.
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 9
Open Access | Times Cited: 4
Luozhu Feng, Yining Zhao, Zhuocheng Yao, et al.
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 9
Open Access | Times Cited: 4
Evolution of ceftazidime-avibactam and cefiderocol resistance in ST131-H30R1- Escherichia coli isolates with KPC-3 mutants and application of FTIR biotyping
Juan Antonio Castillo-Polo, Marta Hernández-García, Ainhize Maruri-Aransolo, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access
Juan Antonio Castillo-Polo, Marta Hernández-García, Ainhize Maruri-Aransolo, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access
Acquired blaCfxA-3 carried by a conjugative transposon or duplicated intrinsic blaCME-3 mediates cefiderocol resistance in Elizabethkingia anophelis clinical isolates
Ya‐Sung Yang, Yu-Lin Lee, Yuag-Meng Liu, et al.
International Journal of Antimicrobial Agents (2024), pp. 107378-107378
Open Access
Ya‐Sung Yang, Yu-Lin Lee, Yuag-Meng Liu, et al.
International Journal of Antimicrobial Agents (2024), pp. 107378-107378
Open Access
A systematic review and individual bacterial species level meta-analysis of in vitro studies on the efficacy of ceftazidime/avibactam combined with other antimicrobials against carbapenem-resistant Gram-negative bacteria
Getnet Mengistu Assefa, Jason A. Roberts, Abdullah Tarık Aslan, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 80, Iss. 2, pp. 334-346
Open Access
Getnet Mengistu Assefa, Jason A. Roberts, Abdullah Tarık Aslan, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 80, Iss. 2, pp. 334-346
Open Access
In-vitro activity of Cefiderocol against clinical isolates of meropenem-resistant Klebsiella pneumoniae from India
Kalyani Borde, M. Abdul Kareem, Ratna Mani Sharma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Kalyani Borde, M. Abdul Kareem, Ratna Mani Sharma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
